Bio-Path Holdings (BPTH)

Bio-Path Holdings (BPTH) Stock Price & Analysis


BPTH Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.35 - $3.58
Previous Close$0.38
Average Volume (3M)353.34K
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)$3.40M
Total Debt (Recent Filing)$168.00K
Price to Earnings (P/E)-0.2
Nov 17, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.24
Shares Outstanding11,460,164
10 Day Avg. Volume61,946
30 Day Avg. Volume353,340
Standard Deviation0.92
Financial Highlights & Ratios
Price to Book (P/B)0.93
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda0.00
Price Target Upside3043.83% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Bio-Path Holdings’s price range in the past 12 months?
Bio-Path Holdings lowest stock price was $0.35 and its highest was $3.58 in the past 12 months.
    What is Bio-Path Holdings’s market cap?
    Currently, no data Available
    When is Bio-Path Holdings’s upcoming earnings report date?
    Bio-Path Holdings’s upcoming earnings report date is Nov 17, 2023 which is in 55 days.
      How were Bio-Path Holdings’s earnings last quarter?
      Bio-Path Holdings released its earnings results on Aug 15, 2023. The company reported -$0.53 earnings per share for the quarter, missing the consensus estimate of -$0.52 by -$0.01.
        Is Bio-Path Holdings overvalued?
        According to Wall Street analysts Bio-Path Holdings’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Bio-Path Holdings pay dividends?
          Bio-Path Holdings does not currently pay dividends.
          What is Bio-Path Holdings’s EPS estimate?
          Bio-Path Holdings’s EPS estimate is -$0.34.
            How many shares outstanding does Bio-Path Holdings have?
            Bio-Path Holdings has 11,460,164 shares outstanding.
              What happened to Bio-Path Holdings’s price movement after its last earnings report?
              Bio-Path Holdings reported an EPS of -$0.53 in its last earnings report, missing expectations of -$0.52. Following the earnings report the stock price went down -11.628%.
                Which hedge fund is a major shareholder of Bio-Path Holdings?
                Currently, no hedge funds are holding shares in BPTH


                Bio-Path Holdings Stock Smart Score

                This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
                Learn more about TipRanks Smart Score

                Company Description

                Bio-Path Holdings

                Bio-Path Holdings, Inc. is a biotechnology company, which engages in the develpment of therapies for acute myeloid leukemia (AML) and chronic myeloid leukemia (CML). Its product pipeline include Prexigebersen, BP1002, and BP1003. The company was founded by Peter Nielsen, Douglas P. Morris, Gabriel Lopez-Berestein and Ana Tari Ashizawa on May 10, 2007 and is headquartered in Bellaire, TX.


                Top 5 ETFs holding BPTH

                Market Value
                Smart Score
                Vanguard Total Stock Market ETF
                iShares Core S&P Total U.S. Stock Market ETF
                Up to five ETFs with an Outperform Smart Score that hold BPTH. The ETFs are listed according to market value of BPTH within the ETF

                Forecast EPS vs Actual EPS

                Similar Stocks
                Price & Change
                Citius Pharmaceuticals
                Infinity Pharma

                Popular Stocks

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis